Suanfarma
About Suanfarma
Certifications
Categories
-
Country/Region:Spain
-
On CPHI since:2015
-
Certificates:3
-
Employees:250 - 499
Company types
Primary activities
Meet us at
CPHI & PMEC China 2026
Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026
CPHI Milan 2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
Products from Suanfarma (10)
-
Product LYMECYCLINE
Lymecycline is a second-generation oral tetracycline prodrug known for its broad-spectrum activity against both Gram-positive and Gram-negative bacteria. It is widely used in the treatment of acne and other susceptible bacterial infections, particularly where good tolerability is essential. -
Product RIBOCICLIB
ONCOLOGY -
Product OXYTETRACYCLINE CALCIUM
ANTIBIOTIC -
Product MINOCYCLINE HYDROCHLORIDE DIHYDRATE
ANTIBIOTIC -
Product TIAMULIN
Antibiotic -
Product CANAGLIFLOZIN
ANTIDIABETIC -
Product MUPIROCIN
Mupirocin is an antibiotic active pharmaceutical ingredient (API) used in formulations for the treatment of bacterial skin infections caused by susceptible Gram-positive bacteria, including Staphylococcus aureus. At Suanfarma, we supply high-quality Mupirocin API to support pharmaceutical development and m... -
Product TAZOBACTAM
Tazobactam is a β-lactamase inhibitor active pharmaceutical ingredient (API) used in combination with certain β-lactam antibiotics to enhance their activity against resistant bacteria. At Suanfarma, we supply high-quality Tazobactam API to support the development and manufacturing of reliable pharmaceutica... -
Product TAZOBACTAM + PIPERACILLIN
Piperacillin + Tazobactam is a combination of a broad-spectrum β-lactam antibiotic and a β-lactamase inhibitor active pharmaceutical ingredients (APIs). This combination enhances antibacterial activity against a wide range of Gram-positive and Gram-negative bacteria by protecting piperacillin from enzymati...
Suanfarma Resources (4)
-
News Suanfarma and the Fight Infections Foundation: a strategic collaboration to advance global health
Suanfarma has initiated a collaboration with the Fight Infections Foundation, an internationally renowned organization with more than three decades of scientific leadership in the study, prevention, and treatment of infectious diseases. This alliance is born from a shared vision: combining capabilities and exploring ways of working together to contribute to global health.
-
Video Revolutionizing Pharma Manufacturing With TT&GO® Technology Transfer
In the rapidly evolving landscape of pharmaceutical manufacturing, the TT&GO® platform by Suanfarma CDMO stands out as a revolutionary solution for technology transfer. This session will explore into the unique methodology of TT&GO®, which integrates rigorous, systematic procedures grounded in risk-based analysis to facilitate seamless technology transfers. Methodological rigor and flexibility: Understanding the systematic approach of TT&GO® that applies to various phases of the product lifecycle, ensuring adaptability and compliance with Good Manufacturing Practices (GMP). Risk management and cost efficiency: Analyzing how TT&GO®'s proactive risk assessment and mitigation strategies lead to reduced failure rates and cost savings, empowering clients to pursue ambitious project timelines with minimized risks. Real-world applications and outcomes: Presenting case studies and success stories of TT&GO® in action, highlighting the platform's impact on accelerating commercial launches and enhancing market competitiveness. Attendees of this session can expect to leave with a comprehensive understanding of how advanced technology transfer methodologies like TT&GO® can be leveraged to optimize pharmaceutical manufacturing processes, ensuring higher efficiency, reduced risk, and better overall outcomes. -
News Suanfarma Appoints Pere Mañé as New CEO to Drive Industrial Growth and Global Expansion
Suanfarma has announced the appointment of Pere Mañé Godina as its new Chief Executive Officer (CEO). This marks the beginning of a new chapter for the company, focused on industrial consolidation, sustainable innovation, and global expansion -
Video Suanfarma, At the Core of a Better Life
Suanfarma is a key player in the life sciences sector, specializing in the development of active pharmaceutical ingredients (APIs) and contract development and manufacturing (CDMO) services. Since 1993, Suanfarma has been dedicated to enhancing global health by improving access to affordable medicines. We operate advanced facilities in Portugal and Italy, and supports over 400 laboratories worldwide through a robust network of 12 commercial offices.
Suanfarma’s proprietary APIs are developed using cutting-edge techniques, including AI and Flow Chemistry, ensuring high standards and GMP compliance. We are committed to sustainability and global health, offering innovative solutions for High Potency APIs and expanding fermentation and chemical synthesis capacities to meet growing global demand.
Our customer-centric approach and strong focus on quality makes us a trusted partner in the pharmaceutical industry.
...






